LONDON, UK: Cellular Goods (LON: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, has launched the inaugural product ranges and ecommerce platform, found at cellulargoods.co.
The launch comprises two product ranges and comes just nine months after the start-up of the Company’s commercial operations following its flotation on the London Stock Exchange.
The inaugural range comprises the UK’s first premium CBG (cannabigerol) skincare offering including a serum, a face-oil and an after-shaving moisturiser.
The products contain ultra-pure, biosynthetic CBG, which has demonstrated anti-inflammatory, anti-oxidant and anti-bacterial properties. All three products have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved.
The second range is a clinically validated CBD (cannabidiol) ingestibles range. This range complies with novel food regulations in both the UK and the EU and is certified under Good Manufacturing Practice (GMP) standards.
The ingestibles range comprises a tincture, a spray and capsules, covering the most popular methods of consumption. These have been extensively tested to ensure safety, stability and quality. Both product ranges do not require the cultivation of the cannabis sativa plant, and contain 0% THC, the psychoactive component of cannabis sativa.
In addition, the company’s new ecommerce platform has gone live, enabling customers in the UK to place online purchase orders for five of the six products as of today. The skincare serum will go on sale from February 2022 due to supply constraints at the Company’s manufacturing partner until early in the new year.
Alexis Abraham, Chief Executive of Cellular Goods, commented: “Today is a major milestone for the Company with the launch of the UK’s first CBG skincare products on a best-in-class ecommerce platform. Leading with CBG sets us apart from the competition, and to also be able to offer consumers CBD ingestibles at the same time delivers on our vision to become the first true cannabinoid company.
We have taken less than a year from a standing start to put Cellular Goods at the forefront of the cannabinoid and wellness industries, and as of today, we have started a new chapter in our growth by entering a revenue-generating phase.
Consumers are now familiar with CBD, and we believe there is a substantial and growing demand for a more innovative and premium brand offering clean, green, and compliant products and look forward to delivering on our potential”.
Leave a Reply